UBS’s BioSpecifics Technologies BSTC Stock Holding History
Bought
Maintained
Sold
Other funds holding BSTC
TC
UBS's BSTC Position: Q3 2014 in Review
UBS sold out of BioSpecifics Technologies (BSTC) in Q3 2014, closing a stake of 825 shares — an estimated $22K sold.
UBS first reported a position in BSTC in Q2 2013 and held it in 4 quarters. The position peaked at $80K in Q2 2013. 68 funds tracked by Wall St. Rank hold BSTC as of Q3 2014.
- UBS reported no remaining BioSpecifics Technologies position as of Q3 2014 after selling out during the quarter.
- UBS sold 825 BioSpecifics Technologies shares in Q3 2014, an estimated $22K.
- UBS first reported a position in BioSpecifics Technologies in Q2 2013 and held it in 4 quarters.
- UBS's BioSpecifics Technologies position peaked at $80K in Q2 2013.
- 68 funds tracked by Wall St. Rank held BioSpecifics Technologies as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.